Latent Tuberculosis Infection in Cancer Patients

计划入组 24 人 · 首次发布于 2007 年 7 月 27 日

Latent Tuberculosis Infection in Renal Transplant Recipients

计划入组 240 人 · 首次发布于 2008 年 5 月 21 日

Treatment of Latent Tuberculosis Infection With Isoniazid

计划入组 200 人 · 首次发布于 2006 年 2 月 17 日

Mycobacterium tuberculosis proteasome 20S inhibitors (Mycobacterium tuberculosis infection)

antitubercular agents (Rutgers University)

4’-phosphopantetheinyl transferase inhibitors (mycobacterium tuberculosis infection)

KNCV TUBERCULOSIS FOUNDATION

Nigeria

TUBERCULOSIS RESEARCH CENTRE

India

FIRST MEDICAL INFECTION CONTROL ASSOCIATES, INC.

United States

Infectious Disease Screening in Substance Use Treatment Programs Shows Dramatic Increases in Detection and Prevention

FDA Expands TOFIDENCE Indications to Include CAR-T Cytokine Release Syndrome and Pediatric COVID-19

FDA Approves Revvity's Automated Latent Tuberculosis Test, Enhancing Diagnostic Efficiency